Quflora Pediatric Tablet, Chewable
NDC Package 15370-104-30
Package Information
Quflora Pediatric (vitamin a acetate, ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, thiamine hydrochloride, riboflavin, niacinamide, pyridoxine hydrochloride, levomefolic acid, folic acid, cyanocobalamin, magnesium oxide, cupric sulfate, and sodium fluoride) tablets is quflora™ Pediatric Chewable Tablets with 0.5 mg Fluoride is a prescription dietary fluoride supplement providing twelve essential vitamins and minerals. This formulation utilizes a tablet, chewable delivery system. Marketed by Carwin Pharmaceutical Associates, Llc, this product is identified by NDC 15370-104.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL, DL- 15 [iU]/1
- ASCORBIC ACID 60 mg/1
- CHOLECALCIFEROL 400 [iU]/1
- CUPRIC SULFATE 1 mg/1
- CYANOCOBALAMIN 4 ug/1
- FOLIC ACID 100 ug/1
- LEVOMEFOLIC ACID 108 ug/1
- MAGNESIUM OXIDE 15 mg/1
- NIACINAMIDE 5 mg/1
- PYRIDOXINE HYDROCHLORIDE 1.5 mg/1
- RIBOFLAVIN 1.3 mg/1
- SODIUM FLUORIDE .5 mg/1
- THIAMINE HYDROCHLORIDE 1.2 mg/1
- VITAMIN A ACETATE 1200 [iU]/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Folate Analog - [EPC] (Established Pharmacologic Class)
- Folic Acid - [CS]
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 15370 - Carwin Pharmaceutical Associates, Llc
- 15370-104 - Quflora Pediatric
- 15370-104-30 - 30 TABLET, CHEWABLE in 1 BOTTLE
- 15370-104 - Quflora Pediatric
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 15370-104-30 identifies a specific commercial package of 30 tablet, chewable in 1 bottle of Quflora Pediatric, a human prescription drug labeled by Carwin Pharmaceutical Associates, Llc. This tablet, chewable is formulated for oral use and contains .alpha.-tocopherol, dl-; ascorbic acid; cholecalciferol; cupric sulfate; cyanocobalamin; folic acid; levomefolic acid; magnesium oxide; niacinamide; pyridoxine hydrochloride; riboflavin; sodium fluoride; thiamine hydrochloride; vitamin a acetate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carwin Pharmaceutical Associates, Llc on January 06, 2014. The current certification is valid through December 31, 2026.
How is this Carwin Pharmaceutical Associates, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 15370010430. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.